Fennec Announces Incremental $5 Million Investment from Petrichor Read more about Fennec Announces Incremental $5 Million Investment from Petrichor
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences Read more about Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023 Read more about Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences Read more about Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023 Read more about Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023
Fennec Announces Results of Annual Meeting Read more about Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients Read more about Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
